US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
ARS Pharmaceuticals Inc (SPRY) 銘柄情報

ARS Pharmaceuticals Inc (SPRY)

8.56

-0.51

(-5.62%)

終了 6月7日 5:00AM

8.50

-0.06

(-0.70%)

取引時間後: 8:59AM

ARS Pharmaceuticals Inc (SPRY) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

8.50

( -6.28% )

買値

8.40

売値

8.97

出来高

1,291,230

8.40 日の範囲 9.1008

6.66 52 週間の範囲 18.90

時価総額

前日終値

9.07

始値

9.00

時刻

最終取引時間

財務取引量

US$ 11,211,267

VWAP

8.6826

平均取引量 (3 か月)

US$ 1,677,697

発行済株式数

99,303,262

配当利回り

PER

-4.69

1 株当たり利益 (EPS)

-2

歳入

98.99M

純利益

-197.98M

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type... ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

ars-pharma.com

本社

San Diego, United States

設立

2026

ARS Pharmaceuticals Inc is listed in the Healthcare sector of the ナスダック市場 with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$9.07. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 6.66 to US$ 18.90.

ARS Pharmaceuticals currently has 99,303,262 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$844.08 million. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.69.

Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies

Former NFL quarterback and 2026 Hall of Fame inductee highlights daily life for people living with severe food...

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

Q1 2026 total revenue of $22.7 million including neffy® (epinephrine nasal spray) U.S. net product revenue of...

Form 8-K - Current report

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical...

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results

SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical...

Form ARS - Annual Report to Security Holders

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.94	-9.95762711864	9.44	9.8693	8.5	1600947	9.07103025	CS
4	-0.66	-7.20524017467	9.16	9.8693	7.03	1827915	8.29320199	CS
12	0.19	2.28640192539	8.31	9.8693	7.03	1670263	8.29237272	CS
26	-1.46	-14.6586345382	9.96	13.14	7.03	1537990	9.33342812	CS
52	-5.25	-38.1818181818	13.75	18.9	6.66	1832382	10.87157033	CS
156	1.27	17.5656984786	7.23	18.9	2.55	1279096	10.57799499	CS
260	3.22	60.9848484848	5.28	18.9	2.55	1199450	10.27776795	CS

SPRY - Frequently Asked Questions (FAQ)

What is the current ARS Pharmaceuticals Inc share price?

The current share price of ARS Pharmaceuticals Inc is US$ 8.50

How many ARS Pharmaceuticals Inc shares are in issue?

ARS Pharmaceuticals Inc has 99,303,262 shares in issue

What is the market cap of ARS Pharmaceuticals Inc?

The market capitalisation of ARS Pharmaceuticals Inc is USD 844.08M

What is the 1 year trading range for ARS Pharmaceuticals Inc share price?

ARS Pharmaceuticals Inc has traded in the range of US$ 6.66 to US$ 18.90 during the past year

What is the PE ratio of ARS Pharmaceuticals Inc?

The price to earnings ratio of ARS Pharmaceuticals Inc is -4.69

What is the cash to sales ratio of ARS Pharmaceuticals Inc?

The cash to sales ratio of ARS Pharmaceuticals Inc is 9.43

What is the registered address of ARS Pharmaceuticals Inc?

The registered address for ARS Pharmaceuticals Inc is 11682 El Camino Real, San Diego, California, 92130

What is the ARS Pharmaceuticals Inc website address?

The website address for ARS Pharmaceuticals Inc is ars-pharma.com

Which industry sector does ARS Pharmaceuticals Inc operate in?

ARS Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

JJPK

Trading like news is eminent

stocksrising

stocksrising 2年前

I’m In!! Going long, and selling naked Nov 12.5 puts ( almost $2 per put) GLTA

EnchantedTitan62

EnchantedTitan62 2年前

Good call on the inhalent, last week FDA approved. Moving up again today. 👍

JJPK

Close to 3mil shares traded in the last minute of trading.
Whats Up.??

Monksdream

Monksdream 2年前

erik007tc

erik007tc 2年前

I believe the fda review/approval will be within 6 months.

Monksdream

Monksdream 2年前

SPRY over $10
Next day settlement begins 5/28 per SEC mandate

dodgerdog

dodgerdog 2年前

Good News around the corner? 🙂

👍️ 1 🤑 1

gail

ah, should have held, lol

gail

not in as i hopped in something else, but watching now.

Pt3

It not going up anytime soon but down Fda denied news

gail

Pt3

gail

i grabbed some today too.

makinezmoney

makinezmoney 3年前

$SPRY:: Fabulous dump down to $2.60 here...............................

OKkkkkkkkkkkkkkkkkkkk.......... lets gooooooooooooooo

GO $SPRY

MiamiGent

MiamiGent 3年前

SPRY Also in ...
ARS PHARMACEUTICALS INC
Pre-market the price per share is $7.85 +$0.10 (1.29%)

https://stockcharts.com/h-sc/ui?s=SPRY

Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $17 Price Target
BENZINGA
8:34 AM ET May-18-2023
Wedbush analyst Andreas Argyrides reiterates ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and maintains $17 price target.

MiamiGent

MiamiGent 3年前

SPRY This is spraying profits all over my screen this morning! I have a very green screen! What's going on, I'm trying to glean.

https://stockcharts.com/h-sc/ui?s=SPRY

MiamiGent

MiamiGent 3年前

SPRY $8.32 +$0.28 (+3.483%)
Moving up after waffling this morning
Volume
2,403,836
90 Day Avg. Vol.
927,230

https://stockcharts.com/h-sc/ui?s=SPRY

ARS Pharmaceuticals

Uranium Royalty

AllianzIM US Equity Buff...

PT BFI Finance Indonesia... (PK)

Western Yilgarn NL

Ci Global Energy Corpora...

Avantis Responsible Emer...

Westar Resources

Tav Havalimalari Holding... (PK)

Mmb Scf 19/29 Mtn Bd02 B...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。